← Leaderboards
Bert Glaser
Ocular Proteomics, Llc
$1,383,746
Attributed
$1,383,746
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $722.1K · FY2010–14$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$1,383,746 · 2
By mechanism
R44$1,206,379 · 1
R43$177,367 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsPublic Health Medicine (Field)Disease ProgressionMicroarray AnalysisProtein MicrochipsProteomicsCostDiagnostic TestsLeadMedicinePatient RightsPhysiciansProteinsProteomeBlindnessAge Related Macular DegenerationDiagnosticClinically SignificantClinical TrialsBaseLiquid SubstanceCommercializationAlternative TherapiesQuality Of Life
Grant awards (3)
Development and Commercialization of Ocular Diagnostic Test Based on Vitreous Pro$484,296
R44 · FY2014 · EY · contact PI
Development and Commercialization of Ocular Diagnostic Test Based on Vitreous Pro$722,083
R44 · FY2013 · EY · contact PI
Development and Commercialization of Ocular Diagnostic Tests Based on Vitreous Pr$177,367
R43 · FY2010 · EY · contact PI